Appili Therapeutics (APLIF) News Today → The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad) Free APLIF Stock Alerts $0.03 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAppili Therapeutics Inc. (APLIF)finance.yahoo.com - April 18 at 2:04 PMAditxt to acquire Appili Therapeutics in strategic moveuk.investing.com - April 4 at 4:32 AMAditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)businesswire.com - April 2 at 8:30 AMAppili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.finance.yahoo.com - April 2 at 8:11 AMAppili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.globenewswire.com - April 2 at 7:30 AMResearchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaksglobenewswire.com - March 12 at 7:12 AMAppili Therapeutics Inc.: Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024finanznachrichten.de - February 14 at 12:51 PMAppili Therapeutics reports Q3 resultsseekingalpha.com - February 14 at 12:51 PMAppili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024finance.yahoo.com - February 13 at 9:16 PMAppili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024globenewswire.com - February 13 at 5:49 PMAppili Therapeutics Inc Ordinary Sharesmorningstar.com - February 3 at 11:33 PMAPLIF: ATI-1701 Program Awarded Additional US$6.6 Million in Funding…finance.yahoo.com - December 6 at 5:29 PMAppili Therapeutics GAAP EPS of -C$0.01msn.com - November 14 at 9:28 PMAppili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2024finance.yahoo.com - November 13 at 7:47 PMAppili Therapeutics’ Biodefense Vaccine Candidate ATI-1701 is Awarded Additional Funding from the U.S. Air Force Academyfinance.yahoo.com - October 25 at 8:27 AMAPLIF: FDA Approves LIKMEZ™ (ATI-1501)…finance.yahoo.com - October 5 at 1:38 PMUPDATE 2-Canada's Appili gets US FDA approval for oral antibiotic solutionca.finance.yahoo.com - September 27 at 2:20 PMAppili Therapeutics Presents at the 10th International Tularemia Conferencefinance.yahoo.com - September 27 at 9:19 AMAppili Therapeutics' Licensing Partner Gets FDA Approval for Metronidazole Oral Suspensionmarketwatch.com - September 25 at 9:04 AMAppili Therapeutics Announces U.S. FDA Approval of LIKMEZ(TM) (ATI-1501) Metronidazole Oral Suspensionstockhouse.com - September 25 at 9:04 AMAppili Therapeutics Says FDA Approves LIKMEZ Metronidazole Oral Suspensionmarkets.businessinsider.com - September 25 at 9:04 AMAppili Therapeutics Announces U.S. FDA Approval of LIKMEZ™ (ATI-1501) Metronidazole Oral Suspensionfinance.yahoo.com - September 25 at 9:04 AMUPDATE 1-Canada's Appili gets US FDA approval for oral antibiotic solutionfinance.yahoo.com - September 25 at 9:04 AMAPLIF: Executes Initial Contract with USAFA for Development of ATI-1701…finance.yahoo.com - July 17 at 2:03 PMAppili Therapeutics Announces Bridge Loan from Bloom Burton & Co.finance.yahoo.com - June 29 at 7:59 AMAppili Therapeutics Full Year 2023 Earnings: CA$0.081 loss per share (vs CA$0.38 loss in FY 2022)finance.yahoo.com - June 28 at 7:27 AMAppili Therapeutics GAAP EPS of -C$0.08seekingalpha.com - June 23 at 1:11 PMAppili Therapeutics Reports Fiscal Year 2023 Financial and Operational Resultsfinance.yahoo.com - June 23 at 8:11 AMAppili Therapeutics Announces Issuance of Patent for ATI-1501 Liquid Oral Reformulation of Metronidazolefinance.yahoo.com - May 24 at 9:56 AMAppili Therapeutics Secures Contract for ATI-1701 Funding from the U.S. Air Force Academyfinance.yahoo.com - May 8 at 8:05 AMAppili Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 18 at 9:29 AMAppili Therapeutics Appoints Dr. Gary Nabors as Chief Development Officerfinance.yahoo.com - April 3 at 10:22 AMAppili Therapeutics Announces Additional Funding of CAD$2.5 million under Non-Convertible Secured Loan with Long Zone Holdingsfinance.yahoo.com - March 20 at 9:34 AMAPLIF: FDA Accepts NDA for ATI-1501; PDUFA Date for September 23, 2023…finance.yahoo.com - February 21 at 1:51 PMAPLI:CA Appili Therapeutics Inc.seekingalpha.com - February 16 at 6:34 AMAppili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2023businesswire.com - February 14 at 7:21 AMAppili Therapeutics Announces that FDA accepts the ATI-1501 NDAfinance.yahoo.com - February 8 at 9:58 AMAppili Therapeutics Appoints Dr. Carl Gelhaus and Arthur Baran to support the ATI-1701 Biodefense Vaccine Programfinancialpost.com - January 17 at 7:14 AMAppili Therapeutics Announces Notice of Allowance from the U.S. Patent and Trademark Office for ATI-1501 Liquid Oral Reformulation of Metronidazolefinance.yahoo.com - January 13 at 10:34 AMAPLIF: Reprioritizing Resources to Focus on ATI-1701, ATI-1801, and ATI-1501…finance.yahoo.com - November 16 at 5:42 PMAppili Therapeutics ATI-1701 Biodefense Vaccine Secures ~US$14 Million of Funding from the U.S. Department of Defense in Partnership with the U.S. Air Force Academyfinance.yahoo.com - November 14 at 9:55 AMAppili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2023finance.yahoo.com - November 10 at 4:30 PMAppili Therapeutics Announces Results of Annual and Special Meeting of Shareholdersfinance.yahoo.com - September 22 at 11:39 PMAppili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2023finance.yahoo.com - August 12 at 4:57 PMAppili Therapeutics to Present at WorldLeish7 Conference in Cartagena, Columbiafinance.yahoo.com - August 2 at 9:02 AMAPLIF: New Late Stage Program to Treat Cutaneous Leishmaniasis…finance.yahoo.com - July 14 at 3:19 PMAppili Therapeutics GAAP EPS of -C$0.38seekingalpha.com - July 1 at 5:01 AMAppili Therapeutics Reports Fiscal Year 2022 Financial and Operational Resultsfinance.yahoo.com - June 29 at 9:37 AMAppili Therapeutics Announces Closing of Public Offering of $4,500,000finance.yahoo.com - May 26 at 10:23 AMAppili Therapeutics launches securities offeringseekingalpha.com - May 18 at 4:24 AM Get Appili Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLIF and its competitors with MarketBeat's FREE daily newsletter. Email Address Just Released: Insider's Secret to Trading Options (Ad)This Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today. Yes! Show Me This Strategy APLIF Media Mentions By Week APLIF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APLIF News Sentiment▼0.000.44▲Average Medical News Sentiment APLIF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APLIF Articles This Week▼10▲APLIF Articles Average Week Get Appili Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLIF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GOVX News ARDS News NEXI News MBIO News EVOK News BCEL News SXTP News PHIO News CING News VRPX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:APLIF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Appili Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
